List of Excipients in API loxapine succinate
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing loxapine succinate
Detailed excipient profiles for loxapine succinate
Excipient focus: ALCOHOL
loxapine succinate drug variants containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
loxapine succinate drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
loxapine succinate drug variants containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
loxapine succinate drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
loxapine succinate drug variants containing D&C RED NO. 33
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing D&C RED NO. 33
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
loxapine succinate drug variants containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
loxapine succinate drug variants containing DIMETHICONE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing DIMETHICONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
loxapine succinate drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
loxapine succinate drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
loxapine succinate drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
loxapine succinate drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
loxapine succinate drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
loxapine succinate drug variants containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
loxapine succinate drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
loxapine succinate drug variants containing METHYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing METHYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLACRILIN POTASSIUM
loxapine succinate drug variants containing POLACRILIN POTASSIUM
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing POLACRILIN POTASSIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
loxapine succinate drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
loxapine succinate drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
loxapine succinate drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
loxapine succinate drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
loxapine succinate drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
loxapine succinate drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | loxapine succinate | 10135-585 |
>Company | >Ingredient | >NDC |
loxapine succinate drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.